本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fennec Pharmaceuticals Inc.

10.66
+0.02000.19%
成交量:8.15萬
成交額:87.49萬
市值:3.74億
市盈率:-88.83
高:10.96
開:10.64
低:10.57
收:10.64
52周最高:13.25
52周最低:5.65
股本:3,506.72萬
流通股本:1,988.67萬
量比:0.49
換手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):-0.1200
每股收益(LYR):-0.3409
淨資產收益率:-18.58%
總資產收益率:-1.16%
市淨率:8.81
市盈率(LYR):-31.27

資料載入中...

2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/20

重要事件披露

Form 8-K - Current report
2024/12/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/27

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals